title: Overshooting the mark: subclinical hyperthyroidism secondary to excess thyroid hormone treatment may be more prevalent than we realise.
authors.forename: Ah-Rin Anna
authors.initials: AR
authors.lastname: Choi
authors.forename: Patrick
authors.initials: P
authors.lastname: Manning
mesh_terms: D006207:Half-Life; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced*; D007037:Hypothyroidism / Q000188:drug therapy; D015995:Prevalence; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D013972:Thyrotropin; D013974:Thyroxine